Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Bourgeois B, Spreitzer E, Platero-Rochart D, Paar M, Zhou Q, Usluer S, et al
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 24304574] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
Subcutaneous dosing in research protocols is typically in the 1-2 mg range, though specific doses depend entirely on the study design and model
REDUCED PAIN AND INFLAMMATION This compound works by not only promoting the healing of injured muscles but also reducing pain and inflammation from rigorous activity
- Tissue regeneration: Promotes angiogenesis and vascular repair via VEGF receptor pathways
